These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

612 related articles for article (PubMed ID: 29726120)

  • 21. Advances in mRNA non-viral delivery approaches.
    Ibba ML; Ciccone G; Esposito CL; Catuogno S; Giangrande PH
    Adv Drug Deliv Rev; 2021 Oct; 177():113930. PubMed ID: 34403751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RNA Nanomedicine: Delivery Strategies and Applications.
    Byun J; Wu Y; Park J; Kim JS; Li Q; Choi J; Shin N; Lan M; Cai Y; Lee J; Oh YK
    AAPS J; 2023 Oct; 25(6):95. PubMed ID: 37784005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent advancements in lipid-mRNA nanoparticles as a treatment option for cancer immunotherapy.
    Karmacharya P; Patil BR; Kim JO
    J Pharm Investig; 2022; 52(4):415-426. PubMed ID: 35369363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cellular Trafficking of Nanotechnology-Mediated mRNA Delivery.
    Huang P; Deng H; Wang C; Zhou Y; Chen X
    Adv Mater; 2024 Mar; 36(13):e2307822. PubMed ID: 37929780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Novel Amino Lipid Series for mRNA Delivery: Improved Endosomal Escape and Sustained Pharmacology and Safety in Non-human Primates.
    Sabnis S; Kumarasinghe ES; Salerno T; Mihai C; Ketova T; Senn JJ; Lynn A; Bulychev A; McFadyen I; Chan J; Almarsson Ö; Stanton MG; Benenato KE
    Mol Ther; 2018 Jun; 26(6):1509-1519. PubMed ID: 29653760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advanced nanoscale delivery systems for mRNA-based vaccines.
    Mobasher M; Ansari R; Castejon AM; Barar J; Omidi Y
    Biochim Biophys Acta Gen Subj; 2024 Mar; 1868(3):130558. PubMed ID: 38185238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Boosting Intracellular Delivery of Lipid Nanoparticle-Encapsulated mRNA.
    Patel S; Ashwanikumar N; Robinson E; DuRoss A; Sun C; Murphy-Benenato KE; Mihai C; Almarsson Ö; Sahay G
    Nano Lett; 2017 Sep; 17(9):5711-5718. PubMed ID: 28836442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lung-Specific mRNA Delivery Enabled by Sulfonium Lipid Nanoparticles.
    Popoola DO; Cao Z; Men Y; Li X; Viapiano M; Wilkens S; Luo J; Teng Y; Meng Q; Li Y
    Nano Lett; 2024 Jul; 24(26):8080-8088. PubMed ID: 38888232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unraveling mRNA delivery bottlenecks of ineffective delivery vectors by co-transfection with effective carriers.
    Oude Egberink R; van Schie DM; Joosten B; de Muynck LTA; Jacobs W; van Oostrum J; Brock R
    Eur J Pharm Biopharm; 2024 Sep; 202():114414. PubMed ID: 39009193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipid nanoparticles for delivery of messenger RNA to the back of the eye.
    Patel S; Ryals RC; Weller KK; Pennesi ME; Sahay G
    J Control Release; 2019 Jun; 303():91-100. PubMed ID: 30986436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipid-Based DNA Therapeutics: Hallmarks of Non-Viral Gene Delivery.
    Buck J; Grossen P; Cullis PR; Huwyler J; Witzigmann D
    ACS Nano; 2019 Apr; 13(4):3754-3782. PubMed ID: 30908008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advances in non-viral mRNA delivery to the spleen.
    Narasipura EA; Fenton OS
    Biomater Sci; 2024 Jun; 12(12):3027-3044. PubMed ID: 38712531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advances in Nonviral mRNA Delivery Materials and Their Application as Vaccines for Melanoma Therapy.
    Neill B; Romero AR; Fenton OS
    ACS Appl Bio Mater; 2024 Aug; 7(8):4894-4913. PubMed ID: 37930174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic mRNA delivery to leukocytes.
    Granot-Matok Y; Kon E; Dammes N; Mechtinger G; Peer D
    J Control Release; 2019 Jul; 305():165-175. PubMed ID: 31121277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent Advances and Challenges in Gene Delivery Mediated by Polyester-Based Nanoparticles.
    Piperno A; Sciortino MT; Giusto E; Montesi M; Panseri S; Scala A
    Int J Nanomedicine; 2021; 16():5981-6002. PubMed ID: 34511901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Customizable Lipid Nanoparticle Materials for the Delivery of siRNAs and mRNAs.
    Fenton OS; Kauffman KJ; McClellan RL; Kaczmarek JC; Zeng MD; Andresen JL; Rhym LH; Heartlein MW; DeRosa F; Anderson DG
    Angew Chem Int Ed Engl; 2018 Oct; 57(41):13582-13586. PubMed ID: 30112821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advances in lipid nanoparticle mRNA therapeutics beyond COVID-19 vaccines.
    Wu Y; Yu S; de Lázaro I
    Nanoscale; 2024 Apr; 16(14):6820-6836. PubMed ID: 38502114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent Advances in Biomaterials for mRNA Delivery to Immune Cells.
    Isaac I; Bhatia M; Bhattacharya C
    ACS Appl Bio Mater; 2024 Aug; 7(8):5136-5146. PubMed ID: 39058246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimization of Lipid Nanoparticle Formulations for mRNA Delivery in Vivo with Fractional Factorial and Definitive Screening Designs.
    Kauffman KJ; Dorkin JR; Yang JH; Heartlein MW; DeRosa F; Mir FF; Fenton OS; Anderson DG
    Nano Lett; 2015 Nov; 15(11):7300-6. PubMed ID: 26469188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evolution of nanomedicine formulations for targeted delivery and controlled release.
    Puri S; Mazza M; Roy G; England RM; Zhou L; Nourian S; Anand Subramony J
    Adv Drug Deliv Rev; 2023 Sep; 200():114962. PubMed ID: 37321376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.